Planeix et al (2015) demonstrated that VEGFR2 negative endothelial cells of breast cancer expressed FSHR and these FSHR positive blood vessels extended 2 mm to 5 mm outside the tumor periphery indicating their involvement in vascular remodeling in anti VEGFR2 resistance breast tumors (Planeix et al. 2015). This evidence concerns the gene FSHR and neoplasm.